APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Precision Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Personalized Precision Medicine Industry Growth and Trends Forecast to 2032

3 March 2026113 pages

Choose your research edition.

Industry ResearchPersonalized Precision Medicine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Precision Medicine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Personalized Precision Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Precision Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Precision Medicine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Personalized Precision Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Precision Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Personalized Precision Medicine market include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Personalized Precision Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Personalized Precision Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Personalized Precision Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Personalized Precision Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Personalized Precision Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Personalized Precision Medicine Market by Company

Agilent Technologies

Biogen

Johnson & Johnson

Boai NKY Pharmaceuticals Ltd.

Novartis

Pfizer

Roche

AstraZeneca

Sanofi

Amgen

Takeda Pharmaceutical

Merck

Eli Lilly

IQVIA

AbbVie

Parexel

Personalized Precision Medicine Segment by Type

Gene Therapy

Personalized Medication

Health Management

Others

Personalized Precision Medicine Segment by Application

Tumors and Cancer

Cardiovascular Diseases

Genetic Disease

Autoimmune Disease

Others

Personalized Precision Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Precision Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Personalized Precision Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Personalized Precision Medicine Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Personalized Precision Medicine Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Personalized Precision Medicine Market Share by Region (2021-2026) Table 4. Global Personalized Precision Medicine Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Personalized Precision Medicine Market Share by Region (2027-2032) Table 6. Global Personalized Precision Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Personalized Precision Medicine Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Personalized Precision Medicine Market Size Share by Type (2021-2026) Table 9. Global Personalized Precision Medicine Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Personalized Precision Medicine Market Size Share Forecasted by Type (2027-2032) Table 11. North America Personalized Precision Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Personalized Precision Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Personalized Precision Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Personalized Precision Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Personalized Precision Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Personalized Precision Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Personalized Precision Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Personalized Precision Medicine Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Personalized Precision Medicine Market Size Share by Application (2021-2026) Table 24. Global Personalized Precision Medicine Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Personalized Precision Medicine Market Size Share Forecasted by Application (2027-2032) Table 26. North America Personalized Precision Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Personalized Precision Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Personalized Precision Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Personalized Precision Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Personalized Precision Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Personalized Precision Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Personalized Precision Medicine Industry Trends Table 37. Personalized Precision Medicine Industry Drivers Table 38. Personalized Precision Medicine Industry Opportunities and Challenges Table 39. Personalized Precision Medicine Industry Restraints Table 40. Global Personalized Precision Medicine Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Personalized Precision Medicine Revenue Market Share by Company (2021-2026) Table 42. Global Personalized Precision Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Personalized Precision Medicine Key Company Headquarters & Area Served Table 44. Global Personalized Precision Medicine Company, Product Type & Application Table 45. Global Personalized Precision Medicine Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Personalized Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Agilent Technologies Company Information Table 49. Agilent Technologies Business Overview Table 50. Agilent Technologies Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Agilent Technologies Personalized Precision Medicine Product Portfolio Table 52. Agilent Technologies Recent Development Table 53. Biogen Company Information Table 54. Biogen Business Overview Table 55. Biogen Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Biogen Personalized Precision Medicine Product Portfolio Table 57. Biogen Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Personalized Precision Medicine Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Boai NKY Pharmaceuticals Ltd. Company Information Table 64. Boai NKY Pharmaceuticals Ltd. Business Overview Table 65. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio Table 67. Boai NKY Pharmaceuticals Ltd. Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Personalized Precision Medicine Product Portfolio Table 72. Novartis Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Personalized Precision Medicine Product Portfolio Table 77. Pfizer Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Roche Personalized Precision Medicine Product Portfolio Table 82. Roche Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AstraZeneca Personalized Precision Medicine Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sanofi Personalized Precision Medicine Product Portfolio Table 92. Sanofi Recent Development Table 93. Amgen Company Information Table 94. Amgen Business Overview Table 95. Amgen Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Amgen Personalized Precision Medicine Product Portfolio Table 97. Amgen Recent Development Table 98. Takeda Pharmaceutical Company Information Table 99. Takeda Pharmaceutical Business Overview Table 100. Takeda Pharmaceutical Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio Table 102. Takeda Pharmaceutical Recent Development Table 103. Merck Company Information Table 104. Merck Business Overview Table 105. Merck Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Merck Personalized Precision Medicine Product Portfolio Table 107. Merck Recent Development Table 108. Eli Lilly Company Information Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Eli Lilly Personalized Precision Medicine Product Portfolio Table 112. Eli Lilly Recent Development Table 113. IQVIA Company Information Table 114. IQVIA Business Overview Table 115. IQVIA Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. IQVIA Personalized Precision Medicine Product Portfolio Table 117. IQVIA Recent Development Table 118. AbbVie Company Information Table 119. AbbVie Business Overview Table 120. AbbVie Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AbbVie Personalized Precision Medicine Product Portfolio Table 122. AbbVie Recent Development Table 123. Parexel Company Information Table 124. Parexel Business Overview Table 125. Parexel Personalized Precision Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Parexel Personalized Precision Medicine Product Portfolio Table 127. Parexel Recent Development Table 128. North America Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Personalized Precision Medicine Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Personalized Precision Medicine Market Share by Country (2021-2026) Table 131. North America Personalized Precision Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Personalized Precision Medicine Market Share Forecast by Country (2027-2032) Table 133. Europe Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Personalized Precision Medicine Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Personalized Precision Medicine Market Share by Country (2021-2026) Table 136. Europe Personalized Precision Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Personalized Precision Medicine Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Personalized Precision Medicine Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Personalized Precision Medicine Market Share by Country (2021-2026) Table 141. Asia-Pacific Personalized Precision Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Personalized Precision Medicine Market Share Forecast by Country (2027-2032) Table 143. Latin America Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Personalized Precision Medicine Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Personalized Precision Medicine Market Share by Country (2021-2026) Table 146. Latin America Personalized Precision Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Personalized Precision Medicine Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Personalized Precision Medicine Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Personalized Precision Medicine Market Share by Country (2021-2026) Table 151. Middle East & Africa Personalized Precision Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Personalized Precision Medicine Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Personalized Precision Medicine Product Image Figure 3. Global Personalized Precision Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Personalized Precision Medicine Market Size (2021-2032) & (US$ Million) Figure 5. Global Personalized Precision Medicine Market Share by Region: 2025 VS 2032 Figure 6. Global Personalized Precision Medicine Market Share by Region (2021-2032) Figure 7. North America Personalized Precision Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Personalized Precision Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Personalized Precision Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Personalized Precision Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Personalized Precision Medicine Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Gene Therapy Image Figure 13. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Personalized Medication Image Figure 15. Global Personalized Medication Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Health Management Image Figure 17. Global Health Management Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Personalized Precision Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Personalized Precision Medicine Market Share by Type 2025 VS 2032 Figure 22. North America Personalized Precision Medicine Market Size Share by Type (2021-2032) Figure 23. Europe Personalized Precision Medicine Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Personalized Precision Medicine Market Size Share by Type (2021-2032) Figure 25. Latin America Personalized Precision Medicine Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Personalized Precision Medicine Market Size Share by Type (2021-2032) Figure 27. Tumors and Cancer Image Figure 28. Global Tumors and Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cardiovascular Diseases Image Figure 30. Global Cardiovascular Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Genetic Disease Image Figure 32. Global Genetic Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Autoimmune Disease Image Figure 34. Global Autoimmune Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Personalized Precision Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Personalized Precision Medicine Market Share by Application 2025 VS 2032 Figure 39. North America Personalized Precision Medicine Market Size Share by Application (2021-2032) Figure 40. Europe Personalized Precision Medicine Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Personalized Precision Medicine Market Size Share by Application (2021-2032) Figure 42. Latin America Personalized Precision Medicine Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Personalized Precision Medicine Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Personalized Precision Medicine Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Personalized Precision Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Personalized Precision Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Personalized Precision Medicine Market Share by Country (2021-2032) Figure 49. Europe Personalized Precision Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Personalized Precision Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Personalized Precision Medicine Market Share by Country (2021-2032) Figure 52. Asia-Pacific Personalized Precision Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Personalized Precision Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Personalized Precision Medicine Market Share by Country (2021-2032) Figure 55. Latin America Personalized Precision Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Personalized Precision Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Personalized Precision Medicine Market Share by Country (2021-2032) Figure 58. Middle East & Africa Personalized Precision Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Personalized Precision Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Personalized Precision Medicine Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Personalized Medication
  • Health Management
  • Others
Applications
  • Tumors and Cancer
  • Cardiovascular Diseases
  • Genetic Disease
  • Autoimmune Disease
  • Others
Companies covered
  • Agilent Technologies
  • Biogen
  • Johnson & Johnson
  • Boai NKY Pharmaceuticals Ltd.
  • Novartis
  • Pfizer
  • Roche
  • AstraZeneca
  • Sanofi
  • Amgen
  • Takeda Pharmaceutical
  • Merck
  • Eli Lilly
  • IQVIA
  • AbbVie
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Personalized Precision Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Personalized Precision Medicine Market Size by Region (2021-2032)
  5. 1.4.1 Global Personalized Precision Medicine Market Size by Region (2021-2026)
  6. 1.4.2 Global Personalized Precision Medicine Market Size by Region (2027-2032)
  7. 1.5 Key Regions Personalized Precision Medicine Market Size (2021-2032)
  8. 1.5.1 North America Personalized Precision Medicine Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Personalized Precision Medicine Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Personalized Precision Medicine Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Personalized Precision Medicine Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Personalized Precision Medicine Market Size Growth Rate (2021-2032)
2 Personalized Precision Medicine Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Gene Therapy
  3. 2.1.2 Personalized Medication
  4. 2.1.3 Health Management
  5. 2.1.4 Others
  6. 2.2 Global Personalized Precision Medicine Market Size by Type
  7. 2.2.1 Global Personalized Precision Medicine Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Personalized Precision Medicine Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Personalized Precision Medicine Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Personalized Precision Medicine Market Size by Regions
  11. 2.3.1 North America Personalized Precision Medicine Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Personalized Precision Medicine Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Personalized Precision Medicine Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Type (2021-2026)
3 Personalized Precision Medicine Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Tumors and Cancer
  3. 3.1.2 Cardiovascular Diseases
  4. 3.1.3 Genetic Disease
  5. 3.1.4 Autoimmune Disease
  6. 3.1.5 Others
  7. 3.2 Global Personalized Precision Medicine Market Size by Application
  8. 3.2.1 Global Personalized Precision Medicine Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Personalized Precision Medicine Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Personalized Precision Medicine Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Personalized Precision Medicine Market Size by Regions
  12. 3.3.1 North America Personalized Precision Medicine Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Personalized Precision Medicine Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Personalized Precision Medicine Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Personalized Precision Medicine Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Personalized Precision Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Personalized Precision Medicine Industry Trends
  2. 4.2 Personalized Precision Medicine Industry Drivers
  3. 4.3 Personalized Precision Medicine Industry Opportunities and Challenges
  4. 4.4 Personalized Precision Medicine Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Personalized Precision Medicine Revenue (2021-2026)
  2. 5.2 Global Personalized Precision Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Personalized Precision Medicine Key Company Headquarters & Area Served
  4. 5.4 Global Personalized Precision Medicine Company, Product Type & Application
  5. 5.5 Global Personalized Precision Medicine Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Personalized Precision Medicine Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Personalized Precision Medicine Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Personalized Precision Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Agilent Technologies
  2. 6.1.1 Agilent Technologies Company Information
  3. 6.1.2 Agilent Technologies Business Overview
  4. 6.1.3 Agilent Technologies Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Agilent Technologies Personalized Precision Medicine Product Portfolio
  6. 6.1.5 Agilent Technologies Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Personalized Precision Medicine Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Personalized Precision Medicine Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Boai NKY Pharmaceuticals Ltd.
  20. 6.4.1 Boai NKY Pharmaceuticals Ltd. Company Information
  21. 6.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
  22. 6.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Portfolio
  24. 6.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Personalized Precision Medicine Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Personalized Precision Medicine Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Roche Personalized Precision Medicine Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Personalized Precision Medicine Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Personalized Precision Medicine Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Amgen
  56. 6.10.1 Amgen Company Information
  57. 6.10.2 Amgen Business Overview
  58. 6.10.3 Amgen Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Amgen Personalized Precision Medicine Product Portfolio
  60. 6.10.5 Amgen Recent Developments
  61. 6.11 Takeda Pharmaceutical
  62. 6.11.1 Takeda Pharmaceutical Company Information
  63. 6.11.2 Takeda Pharmaceutical Business Overview
  64. 6.11.3 Takeda Pharmaceutical Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Takeda Pharmaceutical Personalized Precision Medicine Product Portfolio
  66. 6.11.5 Takeda Pharmaceutical Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Merck Personalized Precision Medicine Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 Eli Lilly
  74. 6.13.1 Eli Lilly Company Information
  75. 6.13.2 Eli Lilly Business Overview
  76. 6.13.3 Eli Lilly Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Eli Lilly Personalized Precision Medicine Product Portfolio
  78. 6.13.5 Eli Lilly Recent Developments
  79. 6.14 IQVIA
  80. 6.14.1 IQVIA Company Information
  81. 6.14.2 IQVIA Business Overview
  82. 6.14.3 IQVIA Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 IQVIA Personalized Precision Medicine Product Portfolio
  84. 6.14.5 IQVIA Recent Developments
  85. 6.15 AbbVie
  86. 6.15.1 AbbVie Company Information
  87. 6.15.2 AbbVie Business Overview
  88. 6.15.3 AbbVie Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AbbVie Personalized Precision Medicine Product Portfolio
  90. 6.15.5 AbbVie Recent Developments
  91. 6.16 Parexel
  92. 6.16.1 Parexel Company Information
  93. 6.16.2 Parexel Business Overview
  94. 6.16.3 Parexel Personalized Precision Medicine Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Parexel Personalized Precision Medicine Product Portfolio
  96. 6.16.5 Parexel Recent Developments
7 North America
  1. 7.1 North America Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Personalized Precision Medicine Market Size by Country (2021-2026)
  3. 7.3 North America Personalized Precision Medicine Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Personalized Precision Medicine Market Size by Country (2021-2026)
  3. 8.3 Europe Personalized Precision Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Personalized Precision Medicine Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Personalized Precision Medicine Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Personalized Precision Medicine Market Size by Country (2021-2026)
  3. 10.3 South America Personalized Precision Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Personalized Precision Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Personalized Precision Medicine Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Personalized Precision Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst